Difluprednate 0.05% versus Prednisolone Acetate 1% for Endogenous Anterior Uveitis: Pooled Efficacy Analysis of Two Phase 3 Studies

John D. SheppardEastern Virginia Medical School, Norfolk, Virginia, USACorrespondence[email protected]
View further author information

, MD,

C. Stephen FosterMassachusetts Eye Research and Surgery Institution, The Ocular Immunology and Uveitis Foundation, Cambridge, Massachusetts, USAView further author information

, MD,

Melissa M. ToyosToyos Clinic, Nashville, Tennessee, USAView further author information

, MD,

Kerry MarkwardtAlcon Laboratories, Fort Worth, Texas, USAView further author information

, PhD,

Robert Da VanzoCornerstone Eye Care, High Point, North Carolina, USAView further author information

, MD,

Thomas E. FlynnEllsworth Uveitis and Retina Care, Ellsworth, Maine, USA;Edward S. Harkness Eye Institute, New York, New York, USAView further author information

, MD &

John H. KempenDepartment of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USA;The Discovery Eye Center, MyungSung Christian Medical Center and MyungSung Medical School, Addis Ababa, EthiopiaView further author information

, MD show all

Difluprednate 0.05% versus Prednisolone Acetate 1% for Endogenous Anterior Uveitis: Pooled Efficacy Analysis of Two Phase 3 Studies

Articles from other publishers (8)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Difluprednate 0.05% versus Prednisolone Acetate 1% for Endogenous Anterior Uveitis: Pooled Efficacy Analysis of Two Phase 3 Studies

Citations (8)

Articles from other publishers (8)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date